Study for Standardization of treatment of children with Helicobacter pylori infection

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027450

Enrollment

Unknown

Registered

2019-11-13

Start date

2018-03-01

Completion date

Unknown

Last updated

2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection in children

Interventions

A:AMO(amoxicillin)-CLA(clarithromycin)-PPI(proton pump inhibitor) 14days

B:MO-CLA -bismuth 14days

C:AMO-CLA-PPI-bismuth 14days

D:PPI-AMO 5 days and PPI-CLA-MET(metronidazole) 5 days

Eligibility

Sex/Gender

All

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: Hp-infected children with indications for eradication

Exclusion criteria

Exclusion criteria: (1) Patients who has received Hp eradication therapy previously; (2) patients who took antibiotics or Bismuth within 1 month and took PPI or H2RA within 2 weeks; (3) patients who are accompanied by serious illnesses of other systems.

Design outcomes

Primary

Measure	Time frame
Urease;MIC value of drug;gastric mucosal microbiota;	—

Countries

China

Contacts

Public ContactZhiling Wang

West China Second Hospital, Sichuan University

wang_zhi_ling@126.com+86 13608072906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026